CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 350 enrolled
Drug / intervention
Albumin + electrolyte solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05059795
NCT05059795N/ACompleted

To Compare the Effectiveness of Various Methods of Estimating Volume Resuscitation in Patients With Cirrhosis With Sepsis Induced Hypotension

Post Graduate Institute of Medical Education and Research, Chandigarh·observational·Posted Sep 28, 2021·Updated Sep 2, 2025

In Brief

An observational study evaluating Albumin + electrolyte solution and POCUS guided fluid resuscitation for Cirrhosis, Liver and 2 related conditions. Completed, enrolled 350 participants across 2 sites.

Detailed Summary

In critically ill patients with liver disease like cirrhosis or ACLF, fluid therapy needs to be instituted after identification of patients who will be fluid responsive and initiate appropriate inotropes early to prevent the mortality associated with fluid overload. The parameters and methodology used for assessing fluid responsiveness have been studied earlier, but the optimum method is not established. Existing recommendations based on data regarding fluid responsiveness and choice of fluid for resuscitation from intensive care units in general cannot be applied to those with liver disease as the hemodynamic alterations that occur with liver disease, presence of hypoalbuminemia at baseline and presence of cardiac dysfunction interfere with the conventional methods of fluid status assessment, fluid responsiveness as well as the response to different types of resuscitation fluids. Therefore the investigators attempt to compare various methods to estimate current intravascular volume status of patient which could be helpful in guiding fluid therapy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 28, 2021
Enrollment StartFeb 1, 2020
Primary CompletionJul 1, 2025
Study CompletionAug 10, 2025
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 4.8 years ago

Interventions

Albumin + electrolyte solutiondrug

Type of resuscitation fluid, dose and use of inotrope

POCUS guided fluid resuscitationother

Conventional goal directed therapy